Patents by Inventor Jacques Acher

Jacques Acher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4039672
    Abstract: The azimido benzamide of this invention and its pharmaceutically acceptable salts have an unusually and unexpectedly high therapeutic index and low toxicity in the treatment of emesis in mammals. Pharmacological testing demonstrated the superior efficacy of the compound of this invention over known, similar compounds.
    Type: Grant
    Filed: March 3, 1975
    Date of Patent: August 2, 1977
    Assignee: Societe d'Etudes Scientifiques et Industrielles de l'Ile-de-France
    Inventors: Gerard Bulteau, Jacques Acher, Claude Collignon, Jean-Claude Monier
  • Patent number: 4029673
    Abstract: The benzamides of this invention and their pharmaceutically acceptable salts are particularly effective in the treatment of emesis and ulcers in mammals. Their low level of toxicity is compatible with use in human therapy, without undesirable side effects.
    Type: Grant
    Filed: March 5, 1975
    Date of Patent: June 14, 1977
    Assignee: Societe d'Etudes Scientifiques et Industrielles de l'Ile-de-France
    Inventors: Gerard Bulteau, Jacques Acher, Jean-Claude Monier
  • Patent number: 3975434
    Abstract: 2,5-Disubstituted benzamides are produced by an efficient, effective and economical method by the utilization of 4-methyl 2-chloro 1-3-2-dioxophosphorinane as a catalyst.
    Type: Grant
    Filed: September 23, 1974
    Date of Patent: August 17, 1976
    Assignee: Societe d'Etudes Scientifiques et Industrielles de l'Ile-de-France
    Inventors: Gerard Bulteau, Jacques Acher, Jean-Claude Monier